Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck

OBJECTIVE: In Japan, cisplatin/5-fluorouracil 80/800 (cisplatin 80 mg/m(2), 5-fluorouracil 800 mg/m(2)) is widely used to treat recurrent/metastatic squamous cell carcinoma of the head and neck, whereas cisplatin/5-fluorouracil 100/1000 (1000 mg/m(2)/24 h by continuous intravenous infusion on Days 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Makoto, Onozawa, Yusuke, Fujii, Hirofumi, Monden, Nobuya, Yana, Ikuo, Otani, Satoru, Hasegawa, Yasuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071043/
https://www.ncbi.nlm.nih.gov/pubmed/24837597
http://dx.doi.org/10.1093/jjco/hyu063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071043/
https://www.ncbi.nlm.nih.gov/pubmed/24837597
http://dx.doi.org/10.1093/jjco/hyu063

Ejemplares similares